Daniel B. Muleta
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 19
-
- Antibiotic Use and Resistance 2
- Co-authors
- Emily Smith (1 shared paper)R. Monina Klevens (1 shared paper)Marion A. Kainer (9 shared papers)Kristin Sweet (1 shared paper)Trudy V. Murphy (1 shared paper)Tasha M. Poissant (1 shared paper)Daniel J. Zaccaro (1 shared paper)Jennifer Baumgartner (1 shared paper)
- Journals
- Open Forum Infectious Diseases (7 papers)Infection Control and Hospital Epidemiology (6 papers)Emerging infectious diseases (3 papers)American Journal of Infection Control (2 papers)JAMA Network Open (1 paper)
- Partner nations
- United StatesAustraliaUganda
In The Last Decade
Daniel B. Muleta
22 papers receiving 445 citations
Peers
Comparison fields: 5 of 46
- Molecular Medicine 265
- Applied Microbiology and Biotechnology 61
- Clinical Biochemistry 13
- Critical Care and Intensive Care Medicine 10
- Pharmacology 30
Countries citing papers authored by Daniel B. Muleta
This map shows the geographic impact of Daniel B. Muleta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel B. Muleta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel B. Muleta more than expected).
Fields of papers citing papers by Daniel B. Muleta
This network shows the impact of papers produced by Daniel B. Muleta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel B. Muleta. The network helps show where Daniel B. Muleta may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel B. Muleta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 98 | |
| 2 | 2020 | 86 | |
| 3 | 2015 | 61 | |
| 4 | 2012 | 59 | |
| 5 | 2018 | 59 | |
| 6 | 2022 | 24 | |
| 7 | 2022 | 20 | |
| 8 | 2023 | 15 | |
| 9 | 2024 | 14 | |
| 10 | 2015 | 10 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 3 | |
| 13 | 2016 | 2 | |
| 14 | 2018 | 2 | |
| 15 | 2018 | 2 | |
| 16 | 2019 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2020 | 1 |
About Daniel B. Muleta
Daniel B. Muleta is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry, Endocrinology and Hepatology, having authored 26 papers that have together received 468 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (19 papers), Bacterial Identification and Susceptibility Testing (2 papers), Antibiotic Use and Resistance (2 papers), Escherichia coli research studies (1 paper), Hepatitis C virus research (1 paper), Hepatitis B Virus Studies (1 paper), Infection Control in Healthcare (1 paper) and Antimicrobial agents and applications (1 paper). The work is most often cited by research in Molecular Medicine (265 citations), Applied Microbiology and Biotechnology (61 citations), Clinical Biochemistry (13 citations), Critical Care and Intensive Care Medicine (10 citations) and Pharmacology (30 citations). Daniel B. Muleta has collaborated with scholars based in United States, Australia and Uganda. Frequent co-authors include Emily Smith, R. Monina Klevens, Marion A. Kainer, Kristin Sweet, Trudy V. Murphy, Tasha M. Poissant, Daniel J. Zaccaro, Jennifer Baumgartner, Sarah F. Schillie and Meredith L. Reilly. Their work appears in journals such as Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Emerging infectious diseases, American Journal of Infection Control and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.